Zinc for the Treatment of COVID-19

Results from early COVID-19 studies are still emerging. Some micronutrients, such as zinc, have been shown to decrease the severity of viral infections yet human data is sparse. Join host, Geoff Wall, as he evaluates a new study looking at the proposed benefit of zinc in COVID-19 infections. The GameChanger Zinc has several antiviral properties. A recent trial showed a decreased risk of ICU admission – however, has numerous exclusion criteria impacting the external validity. Show Segments 00:00 - Introductions 01:45 - Zinc Role In COVID-19 04:20 - Looking at the Study 10:33 - The GameChanger: Study Results 19:03 - Connecting to Practice: Applicability of Exclusions 21:48 - Closing Remarks Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health References and Resources Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial, Clinical Infectious Diseases A Potential Role for Zinc to Enhance Treatment for Coronavirus Disease 2019 (COVID-19) Redeem your CPE or CME here CPE (Pharmacist) CME (Physician) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a membership Prescribers: Get a membership CE Information Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the putative role of zinc in treating COVID-19 2. Describe the application of the results of the Zinc COVID-19 study 0.05 CEU/0.5 Hr UAN: 0107-0000-23-025-H01-P Initial release date: 01/23/2023 Expiration date: 01/23/2024 Additional CPE and CME details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram